Natural Abs specific for the carbohydrate Ag Gal␣1-3Gal␤1-4GlcNAc-R (␣Gal) play an important role in providing protective host immunity to various pathogens; yet little is known about how production of these or other anti-carbohydrate natural Abs is regulated. In this study, we describe the generation of Ig knock-in mice carrying functionally rearranged H chain and L chain variable region genes isolated from a B cell hybridoma producing ␣Gal-specific IgM Ab that make it possible to examine the development of B cells producing anti-carbohydrate natural Abs in the presence or absence of ␣Gal as a self-Ag. Knock-in mice on a ␣Gal-deficient background spontaneously developed ␣Gal-specific IgM Abs of a sufficiently high titer to mediate rejection of ␣Gal expressing cardiac transplants. In the spleen of these mice, B cells expressing ␣Gal-specific IgM are located in the marginal zone. In knock-in mice that express ␣Gal, B cells expressing the knocked in BCR undergo negative selection via receptor editing. Interestingly, production of low affinity ␣Gal-specific Ab was observed in mice that express ␣Gal that carry two copies of the knocked in H chain. We suggest that in these mice, receptor editing functioned to lower the affinity for self-Ag below a threshold that would result in overt pathology, while allowing development of low affinity anti-self Abs. The Journal of Immunology, 2008, 180: 3839 -3848. N atural Abs, those produced without intentional immunization, play a major role in providing protective host immunity (1-3). However, the study of natural Abs has been difficult because in many cases their Ag specificity is unknown. The specificity of many natural Abs remains undefined; however, a significant portion are specific for carbohydrates such as blood group Ags. In addition to anti-ABO blood group Abs, natural Abs specific for a carbohydrate Ag Gal␣1-3Gal␤1-4Glc-NAc-R (␣Gal), represent a significant population of natural Abs (4 -11). The ␣Gal Ag is synthesized by the glucosyltransferase UDP galactose:␤-D-galactosyl-1,4-N-acetyl-D-glucosaminide ␣(1-3) galactosyltransferase (Enzyme classification E.C. 2.4.1.151), or ␣GT. All placental mammals except humans, apes and Old World monkeys express a functional ␣GT enzyme and ␣Gal epitopes on most tissues (12), and are consequently tolerant to ␣Gal because it is recognized as part of self. In contrast, humans, apes and Old World primates carry a nonfunctional ␣GT gene whose function appears to have been lost ϳ30 million years ago (5). Because these species do not recognize ␣Gal structures as self, they consequently produce ␣Gal-specific Abs.
N atural Abs, those produced without intentional immunization, play a major role in providing protective host immunity (1) (2) (3) . However, the study of natural Abs has been difficult because in many cases their Ag specificity is unknown. The specificity of many natural Abs remains undefined; however, a significant portion are specific for carbohydrates such as blood group Ags. In addition to anti-ABO blood group Abs, natural Abs specific for a carbohydrate Ag Gal␣1-3Gal␤1-4Glc-NAc-R (␣Gal), represent a significant population of natural Abs (4 -11) . The ␣Gal Ag is synthesized by the glucosyltransferase UDP galactose:␤-D-galactosyl-1,4-N-acetyl-D-glucosaminide ␣(1-3) galactosyltransferase (Enzyme classification E.C. 2.4.1.151), or ␣GT. All placental mammals except humans, apes and Old World monkeys express a functional ␣GT enzyme and ␣Gal epitopes on most tissues (12) , and are consequently tolerant to ␣Gal because it is recognized as part of self. In contrast, humans, apes and Old World primates carry a nonfunctional ␣GT gene whose function appears to have been lost ϳ30 million years ago (5) . Because these species do not recognize ␣Gal structures as self, they consequently produce ␣Gal-specific Abs.
␣Gal-specific natural Abs are estimated to comprise 1-8% of circulating Ig in humans, and ϳ1% of EBV-transformed peripheral blood B cells make Abs that bind ␣Gal (6, 13) . In humans, ␣Gal-specific Abs are encoded for by a restricted set of Ig Vh genes from the V H 3 family (14) . Production of Abs specific for ␣Gal is believed to be elicited in response to normal bacterial flora that colonize the human gastrointestinal tract (11, 15) . The presence of anti-␣Gal Ab in serum and secretory fluids, such as colostrum and saliva, suggests that these Abs have evolved to play a protective role in primate immunity. Viruses produced in ␣GT-expressing cells that display ␣Gal-modified glycoproteins within their envelop, such as lymphocytic choriomeningitis virus, Newcastle disease virus and vesicular stomatitis virus, as well as C-type retroviruses, have all been shown to be susceptible to inactivation by serum anti-␣Gal Abs (16, 17) . ␣Gal-specific Abs are therefore believed to play an important role in preventing cross-species infection by pathogens. ␣Gal-specific Abs have also been shown to play an important role in rejection of xenogeneic tissue when transplanted into non-human primates (18 -22) . Despite the importance of ␣Gal-reactive Abs to host immunity little is known about how development of B cells producing ␣Gal-reactive or other anticarbohydrate Abs is regulated.
␣Gal-deficient mutant mice lacking a functional ␣GT gene (GT 0/0 mice) generated by gene targeting in embryonic stem cells lack expression of ␣Gal epitopes and consequently develop ␣Gal-specific natural Abs, the majority of which are IgM (23) (24) (25) . The serum titer of ␣Gal-specific Abs in GT 0/0 mice increases in an age-dependent fashion. ␣Gal-specific Abs in GT 0/0 mice share many features with human ␣Gal-specific Abs, including usage of related V genes (26 -31) . These mice therefore represent a small animal model in which ␣Gal-reactive Abs can be studied. However, the frequency of B cells that produce ␣Gal-specific Abs in these mice is low, making direct analysis of B cells producing ␣Gal-specific Abs difficult. We and others have generated Ig transgenic mice to study regulation of B cells producing ␣Gal-specific Abs (32, 33) . However, the use of these mice to address several aspect of B cell development is limited because the Ig transgenes are randomly integrated. They are not transcriptionally regulated in an identical fashion to endogenous Ig genes, and in the case of Ig L chain transgenes, unlike endogenous self-reactive rearranged L chain genes, are not subject to deletion during receptor editing. Therefore, to develop a mouse model in which regulation of ␣Gal-specific Ab production could be studied, we used gene targeting in embryonic stem cells to construct Ig gene knock-in mice. To this end, the rearranged V H and V L regions encoding specificity for ␣Gal were isolated from M86, a hybridoma (IgM, L chain), derived from GT 0/0 mice (34) . M86V H V L knock-in mice were generated on either an Ag-deficient GT 0/0 or Ag-sufficient GT ϩ/ϩ or GT ϩ/Ϫ background to address fundamental issues in regulation of anti-carbohydrate natural Abs. Using these mice, we examined the source of B cells producing ␣Gal-specific Abs and mechanisms leading to negative selection of B cells producing anticarbohydrate Abs. Our data indicate that restricting the ability of B cells producing self-reactive anti-carbohydrate Ags to undergo receptor editing significantly affects B cell development and allows for the production of low affinity anti-self Abs.
Materials and Methods
Mice C57BL/6 GT 0/0 mice and derivation of the colony used in these studies have been described in (35) . C57BL/6 and BALB/c mice were used as controls and were obtained from The Jackson Laboratory. All mice were housed in viral Ab-free microisolator conditions. All animal experiments were conducted in accordance with Institutional guidelines.
Generation of M86V H V L knock-in mice
The functionally rearranged M86 VDJ H and VJ regions were isolated using standard genomic cloning techniques. To construct Ig H chain and L chain targeting vectors the rearranged M86V H and V L gene segments were then cloned using standard techniques into the plVhL2Neo (36) and pVKRNeo (37) H and L chains targeting vectors kindly provided by Dr. K. Rajewsky (Immune Disease Institute, Harvard Medical School, Boston, MA). Vector integrity was confirmed by restriction mapping. Gene targeting and generation of chimeric mice was performed essentially as described (38) . Briefly, each targeting vector was linearized and transfected separately into ES-J1 embryonic stem cells. Transfected cells were selected in presence of G418 (300 mg/ml) and gancyclovir (2 mM). DNA prepared from double drug-resistant colonies was then screened for the presence of homologous recombination by Southern blotting. ES clones containing either the targeted M86V H or V L regions were injected into C57BL/6 blastocysts and then transferred into (BALB/c ϫ C57BL/6) F 1 foster mothers. Blastocyst injection, and embryo transfer, was performed by the Massachusetts General Hospital Microinjection Core Facility (Boston, MA). Chimeric mice were mated to C57BL/6 mice. DNA prepared from tail biopsy samples of resulting offspring was analyzed by Southern blotting to confirm germline transmission. Resulting knock-in mice were then crossed with cre mice (provided by the Massachusetts General Hospital Core Facility) to delete the Neo r gene from targeted H chain and L chain loci. Resulting knock-in mice were then crossed to GT 0/0 mice on the C57BL/6 background to generate M86V H GT ϩ/0 and M86V L GT ϩ/0 mice. These mice were then bred to generate ␣Gal expressing M86V H V L GT ϩ/0 and ␣Gal-deficient M86V H V L GT 0/0 mice.
Flow cytometry and Abs
Single cell suspensions were prepared from blood or lymphoid tissues and then stained and analyzed by flow cytometry as described (35) . ␣Gal epitopes were detected using the Gal-specific IB4 lectin (Sigma-Aldrich) from Bandeiraea simplicifolia (BS-I isolectin B4) (39) . The following Abs used in this study were purchased from BD Pharmingen: RA3-6B2 (anti-CD45R/B220), 187. 
ELISA
ELISAs were conducted as previously described (35) . Briefly, ELISA plates (Corning) were coated overnight at 4°C with either ␣Gal conjugated to BSA (Gal-BSA) or lactosamine conjugated to BSA (Lac-BSA; V-Labs) in carbonate buffer (pH 9.5), and then washed with PBS containing 0.05% Tween 20 (PBS-Tween 20). Lac-BSA shares all determinants with Gal-BSA, except for the terminal galactose structure, and serves as a specificity control. The wells were blocked with 1% BSA in PBS-Tween for 1 h at room temperature and then washed. Serum samples were serially diluted in PBS-Tween 20, added to the plates, and incubated for 1 h at 37°C. The plates were then washed extensively with PBS-Tween 20, and bound Abs were detected using HRP-conjugated goat anti-mouse IgM (1/4000; Jackson ImmunoResearch Laboratories). To determine the relative contribution of transgene-encoded vs endogenously encoded anti-␣Gal, bound Abs were detected with purified biotinylated RS3.1 or MB86, followed by HRP-conjugated streptavidin (1/800; Amersham Biosciences). The plates were incubated for 1 h at 37°C and then washed five times with PBSTween 20. A total of 0.01 mg/ml o-phenylenediamine dihydrochloride (Sigma-Aldrich) in substrate buffer was then added for 20 min at room temperature to develop the assays. The reaction was terminated by adding sulfuric acid to each well, and absorbency was read at 492 nm. Background values obtained from Lac-BSA-coated plates were subtracted from those obtained using Gal-BSA-coated plates. Assays were performed in duplicate. In some instances, serum from immunized mice was used. Mice were immunized i.p. with 10 7 irradiated (3000 rad) pig PBMC as described (42) .
Anti-␣Gal B cell ELISPOT assay
Multiscreen-HA plates (Millipore, Bedford, MA) were coated with 10 g/ml of either Gal-BSA or Lac-BSA in PBS at 4°C overnight. The plates were then washed three times with PBS, allowing the plates to soak for 5 min between each wash. The plates were blocked with IMDM containing 0.4% BSA and penicillin and streptomycin for 2 h at 37°C. The blocking medium was then removed and 10-fold serial dilutions (starting at 1 ϫ 10 6 cells per well) of spleen cells prepared in blocking IMDM were added to the wells. The cells were incubated at 37°C in 5% CO 2 for 24, 48, or 72 h in the presence or absence of LPS (0.5 g/well). After culture, the plates were washed three times in PBS, followed by three additional washes in PBS-Tween 20. HRP-conjugated goat anti-mouse IgM was then added to each well and incubated for 2 h at 4°C. The plates were washed three more times with PBS-Tween 20, followed by PBS, at which point the assays were developed by adding filtered chromogen substrate (3-amino-9-ethylcarbazole) in acetate buffer (pH 5.0). Plates were incubated in the presence of chromogen substrate at room temperature for 5 min and the reaction terminated by washing the plate with water. Spots were enumerated using an automated ELISPOT reader (ImmunoSpot; Cellular Technology). In all assays, the number of background spots obtained on Lac-BSA-coated plates was subtracted from the number obtained on corresponding Gal-BSA-coated plates. All samples were plated in duplicate.
Cell culture B cell precursors from M86V H V L -GT 0/0 mice were grown in vitro as previously described (43, 44) . Briefly, bone marrow cells were depleted of erythrocytes and were cultured in BMB220 medium (IMDM supplemented with 10% FCS, 2-ME, L-glutamine, penicillin/streptomycin, and 50 -100 U/ml recombinant murine IL-7; R&D Systems) at a concentration of 2 ϫ 10 6 cells/ml for 5 days. Washed cells were then cultured for 2-42 h in the absence of IL-7 in wells with irradiated (2000 rad) confluent primary adherent bone marrow-derived stroma from Ag-negative GT 0/0 or Ag-bearing wild-type C57BL/6 mice. After culturing the cells on the stroma, nonadherant pre-B cells were washed and frozen at Ϫ80°C until RNA was extracted. Stromal cultures were initiated by plating erythrocyte-depleted bone marrow cells to confluence in stromal medium (RPMI 1640, 5% FCS, 2-ME, L-glutamine, penicillin/streptomycin, sodium pyruvate, and nonessential amino acids) for 3 days, then washing away nonadherent cells and allowing the adherent stroma to grow for at least 2 wk before use. Stromal cell lines were tested for the expression of ␣Gal by staining with ␣Gal-specific IB4 lectin.
Detection of RAG2 expression
RNA was prepared from cells using an RNeasy mini kit (Qiagen). Complementary DNA was prepared from DNaseI-treated (Invitrogen Life Technologies) RNA with oligo(dT) primers with the Superscript firststrand synthesis kit (Invitrogen Life Technologies). Primer sequences used are as follows: RAG2 forward primer, 5Ј-CACATCCACAAGCA GGAAGTACAC-3Ј; RAG2 reverse primer, 5Ј-GGTTCAGGGACATC TCCTACTAAG-3Ј; ␤-actin forward primer, 5Ј-ACCCCAAGGCCAAC CGCGAGAAGATGACC-3Ј; ␤-actin reverse primer, 5Ј-GGTGATGA CCTGGCCGTCAGGCAGCTCGTA-3Ј. PCR were performed in a final volume of 50 l using 3-5 l of cDNA and 2 U Taq polymerase (Fischer Scientific) on a GeneAmp PCR 2400 thermal cycler (PerkinElmer). Except for the first cycle, which had a 2 min 94°C denaturation step, each cycle consisted of 1 min at 94°C, 1 min at 60°C, and 1 min at 72°C, with a 7 min 72°C extension cycle to end the PCR. For PCR analysis, 35 cycles was used. The PCR product was then fractionated by agarose gel electrophoresis, transferred to Hybond-N nylon membranes (Amersham Biosciences) and RAG2 amplicons detected by hybridization to 32 P-labeled RAG2 probes as described (45) .
RAG2 expression was also analyzed by quantitative real-time PCR. One microgram of total RNA was reverse transcribed using the SuperScript III First-Strand Synthesis SuperMix for quantitative real-time PCR kit (Invitrogen Life Technologies) and used to quantitate relative levels of RAG2 expression using the TaqMan predeveloped assay Mm00501300_m1 for RAG2, and 4352932E for GADPH (Applied Biosystems). The assays were performed in triplicates following standard protocols. The values shown are presented as the difference in cycle threshold (C t ) values normalized to GADPH for each sample (RQ).
Data analysis and reproducibility
Data throughout the study are representative of experiments containing at least three age-and sex-matched mice per group. All experiments have been shown to be reproducible by multiple individuals and have been conducted and confirmed on multiple occasions.
Results

Construction of M86V H V L Ig knock-in mice
The low frequency of B cells that produce ␣Gal-specific Abs in GT 0/0 mice (25, 46, 47) limits the use of these mice to study the regulation of ␣Gal-specific Ab production. To develop a mouse model in which B cells producing ␣Gal-specific Abs could be directly tracked during their development, we generated Ig knock-in mice that express an ␣Gal-specific BCR. To this end, the rearranged Ig H chain and L chain variable region segments were cloned from the hybridoma M86. M86 was derived from GT 0 mice and produces an ␣Gal-specific IgM Ab that uses a L chain (26, 32, 34) . The H chain (rearranged to Jh4) and L chain (rearranged to J1) variable region gene segments were then cloned into the plVhL2Neo (36) and pVKRNeo (37) H and L chains Ig targeting vectors. Each targeting vector was then electroporated separately into 129/Sv embryonic stem cells (ES-J1) as described (38) . ES clones containing either the targeted M86V H or M86V L region were then injected separately into C57BL/6 blastocysts that were then transferred into (BALB/c ϫ C57BL/6) F 1 foster mothers to generate chimeric mice as described (38) . Offspring carrying a knocked in M86V H or M86V L allele were then crossed with Cre recombinase transgenic mice to delete the neomycin resistance gene from targeted H chain and L chain loci. Resulting knock-in mice were then crossed to GT 0/0 mice on the C57BL/6 background to generate M86V H GT ϩ/0 and M86V L GT ϩ/0 mice (Fig. 1A ) that were then bred to generate ␣Gal-expressing M86V H V L GT ϩ/0 mice and ␣Gal-deficient M86V H V L GT 0/0 mice. 
Characterization of ␣Gal-specific Ab production in M86V H V L knock-in mice
Analysis of natural serum Abs revealed that M86V H V L GT 0/0 mice contain high titers of ␣Gal-specific Ab in their serum (Fig. 1B) . The level of ␣Gal-specific Abs in M86V H V L GT 0/0 mice was significantly higher than that observed in GT 0/0 controls at all ages examined (Fig. 1B) . Immunization of M86V H V L GT 0/0 mice with ␣Gal-expressing pig cells led to an increase in the titer of ␣Gal-specific Abs (Fig. 1B) . In contrast, we were unable to detect production of ␣Gal-specific Abs in the serum of M86V H V L GT ϩ/0 or M86V H V L GT ϩ/ϩ mice even after immunization (Fig. 1B) (Fig. 1C) . B cells spontaneously producing ␣Gal-specific Abs were detected in the spleen, lymph node, and bone marrow but not the peritoneum of M86V H V L GT 0/0 mice (Fig. 1D) . Immunization with pig cells did not result in the detection of ␣Gal-producing B cells in the peritoneum of immunized M86V H V L GT 0/0 mice (data not shown). The frequency of ␣Gal-producing B cells in the spleen, bone marrow, and lymph nodes of M86V H V L GT 0/0 mice was at least 10-fold higher than in GT 0/0 controls (Fig. 1D ). We were unable to detect B cells producing ␣Gal-specific Abs in lymphoid tissues from M86V H V L GT ϩ/0 or M86V H V L GT ϩ/ϩ mice (Fig. 1D ). We next examined whether the titer of ␣Gal-specific Abs in M86V H V L GT 0/0 mice was sufficient to induce Ab-mediated transplant rejection. MHC-matched hearts from littermate M86V H V L GT ϩ or C57BL6 mice were heterotopically transplanted into the abdomen of M86V H V L GT 0/0 mice. Hearts from M86V H V L GT ϩ and C57BL/6 mice were uniformly rejected within 24 -72 h. In contrast, hearts from M86V H V L GT 0/0 mice were accepted long-term (Fig. 1E) . These data suggest that ␣Gal-specific (48, 49) , were present in similar proportions to those observed in normal mice, although the frequency of each of these fractions was reduced when compared with normal controls (Fig. 2A) , as observed in other Ig knock-in mice (32, 33) . The frequency of pre-B cells was similar in
The majority of B220 ϩ B cells in the bone marrow of M86V H V L GT ϩ and M86V H V L GT 0/0 mice expressed the knocked in H chain allele (B220 ϩ , sIgM aϩ ) (40.4 Ϯ 9.3% and 46.6 Ϯ 10.1%, respectively) rather than endogenously encoded (B220 ϩ , sIgM bϩ ) allele reflecting exclusion by the rearranged M86V H gene (Fig. 2B) . Essentially all of the B220 ϩ , sIgM aϩ B cells in the bone marrow of M86V H V L GT 0/0 mice were able to bind ␣Gal as determined by staining with fluorescently labeled BSA conjugated to ␣Gal (␣Gal-BSA) (Fig. 2C) . B220 ϩ , sIgM bϩ B cells able to bind ␣Gal-BSA were not detected in M86V H V L GT ϩ or M86V H V L GT 0/0 mice (Fig. 2C) . Staining of M86V H V L GT 0/0 bone marrow cells for expression of B220 and CD43 revealed that B cells capable of binding ␣Gal-BSA were CD43 Ϫ , pre-B or newly formed B cells (Fig. 2D) . B cells able to bind ␣Gal were not detected in the bone marrow of M86V H V L GT ϩ mice, suggesting that B cells expressing the knocked in transgene are tolerized during their development (Fig. 2C) .
Receptor editing prevents the development of B cells producing self-reactive Abs
Because the frequency of B cells expressing surface IgM a (sIgM a ) 3 in the bone marrow of M86V H V L GT ϩ is relatively high (Fig. 2B ) even though we were unable to detect B cells that bind ␣Gal in the bone marrow of M86V H V L GT ϩ mice (Fig. 2C) we reasoned that tolerance to ␣Gal in M86V H V L GT ϩ mice was not deletional. We 3 Abbreviations used in this paper: sIgM, surface IgM; MZ, marginal zone. (Fig. 3A) . Analysis of RAG2 expression by quantitative real-time PCR confirmed this finding (Fig. 3B) . These data suggest that pre-B cells producing self-reactive anti-carbohydrate Abs undergo tolerance through a mechanism that involves receptor editing.
Peripheral B cell development in M86V H V L knock-in mice
We next characterized B cell development in the periphery of M86V H V L mice. In the spleen of M86V H V L GT 0/0 and M86V H V L GT ϩ/0 mice the majority of B cells were B220 ϩ , sIgM aϩ (51.8 Ϯ 8.3% and 69.4 Ϯ 7.6%, respectively) with the frequency of B220 ϩ , sIgM aϩ B cells being slightly higher in M86V H V L GT ϩ/0 mice (Fig. 4A ). B220 ϩ , sIgM bϩ B cells were detected in both types of mice (Fig. 4A) . When compared with bone marrow (Fig. 2B) , the proportion of B220 ϩ , sIgM bϩ B cells observed was higher in the spleen of both M86V H V L GT 0/0 and M86V H V L GT ϩ/0 mice (Fig. 4A) . B cells expressing both sIgM a and sIgM b were not detected in either M86V H V L GT 0/0 or M86V H V L GT ϩ/0 mice, suggesting allelic exclusion by the knocked in H chain (Fig. 4B) . As observed in the bone marrow, B cells capable of binding ␣Gal were detected in the spleen of M86V H V L GT 0/0 but not M86V H V L GT ϩ/0 mice (Fig. 4C) . Although we were unable to detect B cells that spontaneously secrete ␣Gal-specific Abs in the peritoneum of M86V H V L GT 0/0 mice (Fig. 1D), B220 ϩ , CD11b ϩ , CD5 Ϫ B cells in the peritoneum were capable of binding ␣Gal in M86V H V L GT 0/0 mice (Fig. 4D) . In both the spleen and peritoneum, B cells able to bind ␣Gal were B220 ϩ , sIgM aϩ . However, B cells in the peritoneum did not produce ␣Gal-specific Abs even after stimulation with LPS (Fig. 4E) . Consistent with data in Fig. 1E , B cells secreting ␣Gal-specific Abs were only observed in the spleen, bone marrow, and lymph nodes.
Immature B cells in the bone marrow first emigrate to the red pulp in the spleen where they can be detected as sIgM high Fig. 5A ). We were unable to detect sIgM low , IgD high , CD21 int follicular B cells capable of binding ␣Gal-BSA (Fig. 5A) . Analysis of tissue sections from the spleens of M86V H V L GT 0/0 mice revealed that essentially all B cells capable of binding ␣Gal-BSA reside in the MZ and were excluded from the follicle (Fig. 5B) . These data suggest that in M86V H V L GT 0/0 mice ␣Gal-binding B cells are committed to a MZ fate.
Increasing M86V H V L copy number alters the fate of ␣Gal-specific B cells when self-Ag is encountered
While breeding M86V H V L knock-in mice, we also generated mice carrying two copies of the knocked in M86V H region and either (Fig. 6 ). These data suggest that the presence of multiple knocked in H chain or L chain alleles affects B cell development. Interestingly, the reduction in B cell numbers is observed only in mice that express ␣Gal as a self-Ag, suggesting that the effect observed may be related to alterations in negative selection.
Production of autoreactive ␣Gal-specific Abs in M86V H 2V L 2GT
ϩ knock-in mice
Our data indicate that B cells producing ␣Gal-specific Abs were efficiently tolerized in M86V H V L GT ϩ ; however, we consistently observed the presence of ␣Gal-specific serum IgM Abs in M86V H 2V L 2GT ϩ mice (Fig. 7A) . These Abs did not bind the control Ag Lac-BSA which shares all determinants with ␣Gal-BSA except for the terminal galactose residue, indicating the binding observed was specific for ␣Gal. Essentially all ␣Gal-specific Abs in these mice were of the M86V H -encoded IgM a allotype (data not shown). The titer of anti-␣Gal Abs in these mice was consistently lower than that observed in littermate M86V H 2V L GT 0/0 and M86V H 2V L 2GT 0/0 mice, but was similar to the titers observed in GT 0/0 control mice (Fig. 7A) . Furthermore, the titers of these Abs could be boosted by pig cell immunization (Fig. 7A) . To confirm these results, spleen cells from pig cell immunized M86V H 2V L 2GT ϩ/0 , C57BL/6 GT ϩ controls and GT 0/0 mice were analyzed for their ability to produce ␣Gal-specific Ab in Ig ELISPOT assays using ␣Gal-BSA-or Lac-BSA-coated plates. We detected B cells producing ␣Gal-specific IgM Abs in the spleens of M86V H 2V L 2GT ϩ mice, at a frequency similar to that observed in immunized GT 0/0 controls (Fig. 7B) . Similar results were observed in M86V H 2V L GT ϩ mice (data not shown). These data suggest that B cells producing self-reactive anti-␣Gal Abs are able to develop in M86V H 2V L 2GT ϩ mice.
The development of B cells producing ␣Gal-specific Ab in M86V H 2V L 2GT ϩ mice may reflect lowered affinity for Ag
The ability to detect anti-␣Gal Abs in M86V H 2V L 2GT ϩ mice was unexpected. To begin to characterize these Abs, we analyzed the capacity of ␣Gal-specific Abs from these mice to bind BSA conjugated to different numbers of ␣Gal epitopes. We were readily able to detect binding of ␣Gal-specific IgM from these mice when using ELISA plates coated with ␣Gal-BSA conjugates in which the molar ratio of ␣Gal to BSA molecules was high (15:1) (Fig.  7C) . However, the ability to detect binding of ␣Gal in these mice was significantly reduced when ELISA plates were coated with ␣Gal-BSA conjugates in which the molar ratio of ␣Gal to BSA was lower (10:1) (Fig. 7C) . Importantly, serum IgM from M86V H V L GT 0/0 (Fig. 7C) and M86V H 2V L 2GT 0/0 (data not shown) was able to bind to both ␣Gal-BSA preparations to a similar degree. These data suggested that ␣Gal-specific Abs produced in M86V H 2V L 2GT ϩ mice exhibit different binding characteristics than those of littermate mice on the GT 0/0 background. We suggest that B cells making self-reactive ␣Gal-specific Abs in M86V H 2V L 2GT
ϩ and M86V H 2V L GT ϩ mice (data not shown) may develop because the Ab they produce exhibits a lowered affinity for ␣Gal.
Discussion
Anti-carbohydrate natural Abs are thought to play a key role in providing protective host immunity and have been well described as being important in mediating transplantation rejection across blood group disparities as well as discordant species. Yet little is known about B cells that produce anti-carbohydrate Abs, in part due to a lack of small animal models in which the development and regulation of B cells producing anti-carbohydrate Abs can be studied in a physiologically relevant manner. The development of GT 0/0 mice has made it possible to begin to address some of these issues. However, the frequency of B cells producing ␣Gal specific Abs in these mice is too low to allow for their direct analysis. We and others have previously attempted to overcome this difficulty by generating Ig transgenic mice that express transgenes encoding ␣Gal-specific Abs (32, 33) . However, these models are limited because the expressed transgenes were not subject to regulation by elements within the endogenous Ig loci, making it difficult to assess physiological relevance. To overcome these issues we used gene targeting in embryonic stem cells to construct Ig knock-in mice that carry rearranged H chain and L chain V regions that encode specificity for ␣Gal that are under regulatory control of the endogenous Ig H chain and L chain loci. Breeding M86V H V L mice to GT 0/0 mice offered us the opportunity to directly examine the development of B cells producing ␣Gal-specific Abs in the presence or absence of ␣Gal as a self-Ag.
M86V H V L GT 0 mice show high serum levels of ␣Gal-specific Abs produced by the knocked in allele. The titer of these Abs was sufficient to mediate rejection of H-2-matched heart transplants from GT ϩ donors. The titer of ␣Gal-specific Abs in M86V H V L GT 0 mice could be increased by immunization. ␣Gal-specific Abs were not detected in the serum of M86V H V L GT ϩ mice, indicating that expression of ␣Gal in these mice prevented development of ␣Gal-specific Abs. However, we were still able to detect sIgM aϩ B cells in the spleens of M86V H V L GT ϩ mice, suggesting that B cells expressing the knocked in M86V H region were not deleted during their development. Because the frequency of B cells expressing surface IgM a in the bone marrow of M86V H V L GT ϩ and M86V H V L GT 0/0 knock-in mice was similar even though we were unable to detect B cells that bind ␣Gal in the bone marrow of M86V H V L GT ϩ mice, we reasoned that tolerance to ␣Gal in M86V H V L GT ϩ mice was most likely the result of receptor editing rather than deletion. Analysis of IL-7 driven pre-B cells from the bone marrow of M86V H V L GT 0/0 mice revealed that exposure to ␣Gal as a self-Ag led to an up-regulation of RAG2 expression in M86V H V L GT 0/0 pre-B cells. These data are consistent with the idea that pre-B cells producing self-reactive anti-carbohydrate Abs undergo tolerance induction via receptor editing in the bone marrow. Interestingly, although receptor editing has been suggested to lead to an increase in the frequency of immature B cells expressing light chains (37, 45, 56), we did not detect an increase in the frequency of B cells expressing a L chain in the bone marrow or periphery of M86V H V L GT ϩ mice (data not shown). Therefore, in this model, receptor editing most likely occurs preferentially on the L chain. At least three distinct mechanisms that shape the naive B cell repertoire have been described, including clonal deletion (57-61); anergy (62, 63) ; and receptor editing (45, 50, 51, 64) . The mechanism by which B cells producing Abs to self-carbohydrate Ags are tolerized has been studied in relatively little detail. Although receptor editing has been described as a major mechanism of B cell tolerance, to our knowledge this is the first description suggesting that receptor editing is the mechanism of tolerance for B cells producing anti-carbohydrate Abs.
Our analysis of B cell development in M86 knock-in mice shows that anti-␣Gal B cells undergo editing at the H chain locus even in the absence of ␣-Gal, resulting in the development of sIgM bϩ B cells. When comparing the frequency of sIgM bϩ B cells in bone marrow and spleen, it is apparent that the relative frequency of such cells is increased in spleen (see Figs. 2 and 4) , suggesting a selection of B cells expressing sIgM bϩ in the periphery. One possibility is that the knocked in H chain does not exclude well and that a selection process in GT ϩ mice ensures that only B cells expressing the endogenous H chain differentiate into peripheral mature lymphocytes. However, based on the analysis shown in Fig. 4B in which we were unable to detect B cells producing both sIgM a and IgM b , we would suggest that apparently allelic exclusion in this system is not very leaky. Rather, there seems to be a selection process by which B cells expressing endogenous sIgM b are selected for in the periphery. It seems reasonable to suggest that this selection would be important to allow for an increase in the diversity of the Ig repertoire.
There is an unresolved issue regarding which B cell subsets produce anti-carbohydrate Abs. Using Ig transgenic mice, it has been suggested previously that B cells producing ␣Gal-specific Abs are skewed to a MZ B cell phenotype (33) . However, the use of Ig transgenic mice has made it difficult to determine whether this observation is of physiological relevance. Analysis of spontaneous ␣Gal Ab production in lymphoid tissue of M86V H V L GT 0/0 mice revealed the presence ␣Gal-specific Ab production in the spleen, bone marrow, and lymph nodes, but not the peritoneum. Analysis of mice carrying two copies of the knocked in M86V H region and either one or two copies of the knocked in M86V L region revealed that copy number can significantly impact B cell development in mice expressing ␣Gal as a self-Ag. ϩ mice that carry two copies of the knocked in L chain allele. Because the effect of copy number on B cell number was seen only in mice expressing ␣Gal as a self-Ag, we suggest that the effect observed is related to alterations in negative selection and that increasing the copy number of knocked in alleles may alter mechanisms of negative selection by restricting receptor editing, thereby skewing tolerance toward a deletional mechanism. This would support the idea that B cells primarily use editing to eliminate self-reactive B cells, and that negative selection via deletion is secondary to receptor editing.
Although B cells producing ␣Gal-specific Abs were efficiently tolerized in M86V H V L mice on the GT ϩ background, we consistently observed the presence of ␣Gal-specific serum IgM Abs in M86V H 2V L 2GT ϩ mice. This unanticipated finding prompted us to examine the binding characteristics of ␣Gal specific Abs in these animals. Interestingly, although we were readily able to detect binding of ␣Gal-specific IgM from these mice when using ELISA plates coated with ␣Gal-BSA conjugates in which the molar ratio of ␣Gal to BSA molecules was high, the ability to detect binding of ␣Gal in these mice was significantly reduced when ELISA plates were coated with ␣Gal-BSA conjugates in which the molar ratio of ␣Gal to BSA was relatively low. These data suggest that ␣Gal-specific Abs in M86V H 2V L 2GT ϩ mice have a lower affinity for ␣Gal than that observed in GT 0 mice. Such low affinity Abs appear to require an increase in binding avidity to be detected, which can be achieved by using BSA molecules that are highly substituted with ␣Gal epitopes. Why then would such Abs develop in mice that express ␣Gal? Although this issue is under study, it is important to point out that production of ␣Gal-specific Abs are produced only in mice containing two copies of the knocked in H chain allele and either one or two copies of the knocked in L chain allele. In M86 mice, the knocked in H chain allele is rearranged to J h 4, which prevents receptor editing but not V gene replacement. We suggest that in the context of multiple copies of the knocked in H chain, V gene replacement via homologous recombination may select for V H genes of similar sequences to the M86V H region, which can encode H chain variable regions that bind ␣Gal with an affinity that is sufficiently low to allow for their development in GT ϩ mice. We are currently evaluating this hypothesis. The development of M86 Ig knock-in mice provides us with a unique model to study the development of B cells producing anticarbohydrate Abs. The initial description of these mice has provided a novel insight into mechanisms of tolerance for B cell producing anti-carbohydrate Abs. Importantly, unanticipated findings resulting from this work may aid our understanding of self-nonself recognition. Although M86V H 2V L 2GT ϩ mice producing ␣Gal-specific Abs appear to be grossly healthy, the presence of ␣Gal-specific Abs in these mice may provide us with a model to examine how autoimmunity can be precipitated and lead to pathology.
